![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
Listed Suppliers
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211045
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209571
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207681
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/alembic-pharmaceuticals-gets-usfda-go-ahead-for-bladder-drug/articleshow/62033929.cms
https://www.prnewswire.com/news-releases/gsk-achieves-approval-for-nucala-mepolizumab-for-the-treatment-of-eosinophilic-granulomatosis-with-polyangiitis-egpa-for-adults-in-the-us-300570186.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207302
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205209
http://www.biospectrumindia.com/biospecindia/news/224417/fda-nod-ciplas-generic
http://economictimes.indiatimes.com/articleshow/54827235.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
https://www.pharmacompass.com/pdf/news/jubilants-generics-darifenacin-hydrobromide-approved-in-us-1477133021.pdf
https://www.pharmacompass.com/pdf/news/aurobindo-pharma-ltd-generic-darifenacin-hydrobromide-approved-in-us-1474551443.pdf
https://www.pharmacompass.com/pdf/news/cipla-gets-usfda-nod-for-overactive-bladder-treating-drug-1473503105.pdf